Barbara Wirostko, Pfizer A- to Present at the 2nd Annual Ocular Disease Conference
March 11th, 2010
Barbara Wirostko will present her topic on Endothelin as a novel target. The benefits of the talk will cover the background and supporting data that exists to support this as a novel MOA and target, the rationale from a pathophysiologic perspective, the impact that modulating this target could have on ocular disease and pathology, and the clinical …
Original post by SBWire
(click on the author/publication link above to see full post)